» Articles » PMID: 9437614

A Structured Instrument for Estimating the Economic Cost of Drug Abuse Treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP)

Overview
Specialty Psychiatry
Date 1998 Jan 23
PMID 9437614
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Drug abuse treatment programs need to know the cost of the services they provide. Indeed, continued public and private funding is now being linked to cost and performance measures, and programs can use financial data to improve organizational efficiency. However, one of the dangers of promoting cost studies at treatment programs is that most program staff are not technically prepared to perform a cost analysis and little user-friendly information is available to offer assistance. Furthermore, not all cost methods are consistent, which can lead to noncomparable estimates that are difficult to use for policy or planning purposes. Our paper tries to fill this gap in the research literature and provide treatment programs with a much-needed technical assistance tool. Specifically, we present a structured and scientifically-based instrument for estimating the economic cost of treatment services. The Drug Abuse Treatment Cost Analysis Program (DATCAP) is described in detail along with a companion instrument to analyze treatment financing; the Drug Abuse Treatment Financing Analysis Program (DATFin). The components of both instruments are outlined and findings from a variety of actual case studies are presented. Lastly, we discuss the DATCAP User's Manual, which will enable individual programs to begin collecting the necessary data and estimating economic costs at their own clinics.

Citing Articles

Cost analysis of MOUD implementation and sustainability in Massachusetts jails.

Ryan D, Ekanayake D, Evans E, Hayes E, Senst T, Friedmann P Health Justice. 2025; 13(1):9.

PMID: 39907840 PMC: 11796061. DOI: 10.1186/s40352-025-00321-z.


Comparative- and Cost-Effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women With HIV to Full Viral Suppression (Text Me, Alexis!): Protocol for a Randomized Controlled Trial.

Reback C, Blue T, Jalali A, Landovitz R, Li M, Mata R JMIR Res Protoc. 2025; 14:e65313.

PMID: 39847410 PMC: 11803334. DOI: 10.2196/65313.


PERSPECTIVE: Health Economic Interests at NIMH and NIDA to Improve Delivery of Behavioral Health Services.

Humensky J, Duffy S, Cubillos L, Freed M, Rupp A J Ment Health Policy Econ. 2024; 27(1):33-39.

PMID: 38634396 PMC: 11268881.


Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services.

Bartholomew T, Plesons M, Serota D, Alonso E, Metsch L, Feaster D Addict Sci Clin Pract. 2024; 19(1):21.

PMID: 38528570 PMC: 10964520. DOI: 10.1186/s13722-024-00447-9.


Establishing a Protocol for Determining the Costs of an Integrated Set of Evidence-based Practices Aimed at Reducing Opioid Overdose Deaths.

Tin Y, Castry M, Bowers-Sword R, Shantharam S, Aldridge A, Zarkin G J Addict Med. 2023; 18(1):13-18.

PMID: 37768777 PMC: 10872250. DOI: 10.1097/ADM.0000000000001218.